New patent for Bristol drug AUGTYRO

Annual Drug Patent Expirations for AUGTYRO Augtyro is a drug marketed by Bristol and is included in one NDA. It is available from one supplier. The generic ingredient in AUGTYRO…

The post New patent for Bristol drug AUGTYRO appeared first on DrugPatentWatch - Make Better Decisions.


Comments are closed.

Biotechblog